Patients taking part in trials of new cancer drugs have unrealistic expectations that experimental treatment will save them, a study by the Royal Marsden has found.
Research on more than 300 cancer patients asked about taking part in early-stage research found almost half believed their tumours would shrink, with hopes rising after they discussed the trials with their doctors.
Read the full article here. This article was first published in The Telegraph online on 26 September 2016. The Royal Marsden study was also reported by The Institute of Cancer Research on 26 September 2016.